1 year return (CAGR)
-81.91%
Kala Pharmaceuticals Inc Exchange (NASDAQ, USD)
KALA
0.30
-0.06 (-17.61%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-67.72%
5 year return (CAGR)
-32.03%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
5.74M
Price/Sales
-
Ent value
7.05M
Price/Book
0.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
16.32%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.35 |
| Daily high | 0.35 |
| Daily low | 0.29 |
| Daily Volume | 655K |
| All-time high | 42.09 |
| 1y analyst estimate | 1.50 |
| Beta | -2.29 |
| EPS (TTM) | -135.92 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KALA | S&P500 | |
| Current price drop from All-time high | -99.30% | -0.66% |
| Highest price drop | -99.81% | -56.47% |
| Date of highest drop | 8 May 2026 | 9 Mar 2009 |
| Avg drop from high | -74.42% | -10.67% |
| Avg time to new high | 122 days | 12 days |
| Max time to new high | 1332 days | 1805 days |
News
